Lunai Bioworks Inc.
LNAI
$2.32
$0.031.09%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -1,459.09% | 75.19% | 106.38% | -705.59% | 100.32% |
| Total Depreciation and Amortization | -125.94% | -65.11% | 28.09% | 4.82% | 5.61% |
| Total Amortization of Deferred Charges | -- | 381.93% | -21.94% | -100.00% | -100.00% |
| Total Other Non-Cash Items | 139.18% | -93.00% | -113.02% | 1,197.55% | -105.83% |
| Change in Net Operating Assets | -75.82% | -56.87% | -50.56% | -57.96% | -69.62% |
| Cash from Operations | 30.96% | 58.15% | 33.09% | 24.97% | 43.52% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.00% | -- | -- | 3,336.24% | -862.16% |
| Cash from Investing | 100.00% | -- | -- | 1,905.99% | -1,498.69% |
| Total Debt Issued | -40.65% | -92.05% | 929.32% | 28.22% | -54.11% |
| Total Debt Repaid | -380.12% | 100.00% | -21.30% | -21.30% | -21.30% |
| Issuance of Common Stock | -100.00% | 167.86% | -- | -- | 200.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 3.33% | -63.33% | -33.80% | -92.77% | 35.71% |
| Foreign Exchange rate Adjustments | 38.68% | -117.86% | 46.88% | -76.36% | -113.85% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 335.80% | -246.05% | 532,000.00% | -800.54% | 789.67% |